Literature DB >> 5485150

Uptake, metabolism and release of (3H)-adrenaline by human platelets.

G V Born, J B Smith.   

Abstract

1. Measurements were made of the uptake, metabolism and release of [(3)H]-adrenaline by human platelets in citrated plasma or in an artificial medium.2. Radioactive adrenaline was not taken up at 0-2 degrees C. At 37 degrees C there was a slow uptake which continued for at least 5 hours.3. About half of the radioactivity in the platelets was intact adrenaline. The other half was an acidic metabolite from which adrenaline was released by acid hydrolysis.4. The immediate uptake of adrenaline was proportional to its concentration in the plasma up to at least 1 x 10(-5)M. Uptake measured after 1 h also increased linearly with concentration up to about 1 x 10(-4)M but less with higher concentrations. The highest concentration ratio was about 12.5. The concentration of metabolite in the platelets increased with the concentration of added adrenaline only up to about 2 x 10(-4)M.6. The immediate uptake of adrenaline was partially inhibited by phentolamine and dihydroergotamine. Measurement of uptake both immediately and after 1 h showed that the inhibition produced was not increased beyond about 50% by these drugs or by (+/-)-propranolol, chlorpromazine or amitriptyline up to 1 x 10(-4)M.7. Formation of the metabolite was inhibited by pyrogallol, 8-hydroxyquinoline, or tropolone. This inhibition was associated with a corresponding increase in the adrenaline accumulated intact. Formation of the metabolite was not inhibited by monoamine oxidase inhibitors.8. Reserpine caused a small decrease in the uptake of adrenaline radioactivity in 1 h and a great increase in the proportion recovered as metabolite.9. Thrombin caused the release from platelets of intact adrenaline but not of the metabolite.10. Platelets of albino patients with spontaneous haemorrhages accumulated adrenaline radioactivity at the normal rate but this radioactivity was wholly accounted for by metabolite and not released by thrombin.11. After taking up adrenaline, platelets resuspended in artificial medium at 37 degrees C slowly released both adrenaline and its metabolite. At the same time, the intracellular adrenaline was slowly metabolized.12. The Result suggest that human platelets take up adrenaline by two processes, one of which is inhibited by both alpha- and beta-adrenoceptor blocking agents ad well as by phenothiazines; and that in the platelets adrenaline is partly stored in organelles from which, like 5-hydroxytryptamine, it can be specifically released.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5485150      PMCID: PMC1702725          DOI: 10.1111/j.1476-5381.1970.tb09903.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  The uptake of 5-hydroxytryptamine by blood platelets in the cold.

Authors:  G V BORN; J BRICKNELL
Journal:  J Physiol       Date:  1959-06-23       Impact factor: 5.182

2.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

3.  A note on the use of cellulose phosphate cation-exchange paper for the separation of catecholamines, and some other biogenic amines.

Authors:  M ROBERTS
Journal:  J Pharm Pharmacol       Date:  1962-11       Impact factor: 3.765

4.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

Authors:  A BERTLER; A CARLSSON; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1958-12-15

Review 5.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.

Authors:  P R Emmons; J R Hampton; M J Harrison; A J Honour; J R Mitchell
Journal:  Br Med J       Date:  1967-05-20

7.  Effect of catecholamines on platelet aggregation caused by thrombin.

Authors:  D P Thomas
Journal:  Nature       Date:  1967-07-15       Impact factor: 49.962

8.  Effects of adrenaline on human blood platelets.

Authors:  D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

9.  The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma.

Authors:  R J Haslam; D C Mills
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

10.  The uptake of adrenaline and noradrenaline by blood platelets of the pig.

Authors:  G V BORN; O HORNYKIEWICZ; A STAFFORD
Journal:  Br J Pharmacol Chemother       Date:  1958-12
View more
  8 in total

1.  Metaraminol uptake by human thrombocytes: a poor model for neuronal noradrenaline uptake.

Authors:  P C Waldmeier; P A Baumann
Journal:  Experientia       Date:  1977-10-15

2.  Catecholamine uptake, accumulation, and release in acute porphyria.

Authors:  M F Beal; N O Atuk; T C Westfall; S M Turner
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

Review 3.  Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.

Authors:  Gabriella Passacquale; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

4.  Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.

Authors:  B Lemmer; G Wiethold; D Hellenbrecht; I J Bak; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.

Authors:  M Da Prada; G B Picotti
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

6.  A common uptake system for serotonin and dopamine in human platelets.

Authors:  G S Omenn; L T Smith
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

Authors:  G V Born; K Juengjaroen; F Michal
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

8.  Liberation of catecholamines from blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol       Date:  1981-02       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.